131 related articles for article (PubMed ID: 34689243)
1. Angiographic disease progression in medically treated adult patients with ischemic moyamoya disease without cerebral misery perfusion: supplementary analysis of a 5-year prospective cohort.
Oomori D; Kubo Y; Yabuki M; Kitakami K; Fujiwara S; Yoshida K; Kobayashi M; Terasaki K; Ogasawara K
Neurosurg Rev; 2022 Apr; 45(2):1553-1561. PubMed ID: 34689243
[TBL] [Abstract][Full Text] [Related]
2. Five-Year Outcomes of Medical Management Alone for Adult Patients with Ischemic Moyamoya Disease without Cerebral Misery Perfusion.
Kitakami K; Kubo Y; Yabuki M; Oomori D; Takahashi T; Igarashi S; Fujiwara S; Yoshida K; Kobayashi M; Terasaki K; Ogasawara K
Cerebrovasc Dis; 2022; 51(2):158-164. PubMed ID: 34518462
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Cognitive Changes after Revascularization Surgery in Adult Patients with Ischemic Moyamoya Disease.
Uchida S; Kubo Y; Oomori D; Yabuki M; Kitakami K; Fujiwara S; Yoshida K; Kobayashi M; Terasaki K; Ogasawara K
Cerebrovasc Dis Extra; 2021; 11(3):145-154. PubMed ID: 34808627
[TBL] [Abstract][Full Text] [Related]
4. Two-Year Clinical, Cerebral Hemodynamic, and Cognitive Outcomes of Adult Patients Undergoing Medication Alone for Symptomatically Ischemic Moyamoya Disease Without Cerebral Misery Perfusion: A Prospective Cohort Study.
Miyoshi K; Chida K; Kobayashi M; Kubo Y; Yoshida K; Terasaki K; Ogasawara K
Neurosurgery; 2019 Jun; 84(6):1233-1241. PubMed ID: 29850833
[TBL] [Abstract][Full Text] [Related]
5. Angiographic, Cerebral Hemodynamic, and Cognitive Outcomes of Indirect Revascularization Surgery Alone for Adult Patients With Misery Perfusion due to Ischemic Moyamoya Disease.
Kimura K; Kubo Y; Dobashi K; Katakura Y; Chida K; Kobayashi M; Yoshida K; Fujiwara S; Terasaki K; Kawamura T; Ogasawara K
Neurosurgery; 2022 Jun; 90(6):676-683. PubMed ID: 35311740
[TBL] [Abstract][Full Text] [Related]
6. Development of cerebral microbleeds and its impact on cognitive function in adult patients receiving medical management alone for ischemic moyamoya disease: supplementary analysis of a 5-year prospective cohort.
Yabuki M; Kubo Y; Kitakami K; Oomori D; Fujiwara S; Yoshida K; Kobayashi M; Ogasawara K
Neurol Res; 2022 Dec; 44(12):1104-1112. PubMed ID: 35975947
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Medical Management Alone for Adult Patients with Cerebral Misery Perfusion Due to Ischemic Moyamoya Disease.
Ogasawara K; Uchida S; Akamatsu Y; Chida K; Kobayashi M; Yoshida K; Fujiwara S; Terasaki K; Kubo Y
J Stroke Cerebrovasc Dis; 2022 Aug; 31(8):106588. PubMed ID: 35671656
[TBL] [Abstract][Full Text] [Related]
8. Delayed development of cerebral atrophy after cerebral hyperperfusion following arterial bypass for adult patients with ischemic moyamoya disease: supplementary analysis of a 5-year prospective cohort.
Katakura Y; Kubo Y; Dobashi K; Kimura K; Fujiwara S; Chida K; Kobayashi M; Yoshida K; Terasaki K; Ogasawara K
Acta Neurochir (Wien); 2022 Apr; 164(4):1037-1045. PubMed ID: 35122551
[TBL] [Abstract][Full Text] [Related]
9. Stroke and Disease Progression During Long-Term Follow-Up of Patients with Moyamoya Disease Older Than 50 Years.
Sakai R; Hara S; Inaji M; Tanaka Y; Nariai T; Maehara T
World Neurosurg; 2024 Jul; 187():e898-e907. PubMed ID: 38734172
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Cerebral Hyperperfusion after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis by Three-Dimensional-Time-of-Flight Magnetic Resonance Angiography in Adult Patients with Moyamoya Disease.
Nishizawa T; Fujimura M; Katsuki M; Mugikura S; Tashiro R; Sato K; Tominaga T
Cerebrovasc Dis; 2020; 49(4):396-403. PubMed ID: 32829323
[TBL] [Abstract][Full Text] [Related]
11. Significance of Quantitative Cerebral Blood Flow Measurement in the Acute Stage after Revascularization Surgery for Adult Moyamoya Disease: Implication for the Pathological Threshold of Local Cerebral Hyperperfusion.
Kameyama M; Fujimura M; Tashiro R; Sato K; Endo H; Niizuma K; Mugikura S; Tominaga T
Cerebrovasc Dis; 2019; 48(3-6):217-225. PubMed ID: 31812964
[TBL] [Abstract][Full Text] [Related]
12. Changes in periventricular anastomosis after indirect revascularization surgery alone for adult patients with misery perfusion due to ischemic moyamoya disease.
Kobayashi M; Akamatsu Y; Chida K; Uchida S; Fujiwara S; Yoshida K; Koji T; Kubo Y; Ogasawara K
Neurosurg Rev; 2022 Dec; 45(6):3665-3673. PubMed ID: 36112252
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Effects between Clopidogrel and Cilostazol on Cerebral Perfusion in Nonsurgical Adult Patients with Symptomatically Ischemic Moyamoya Disease: Subanalysis of a Prospective Cohort.
Chiba T; Setta K; Shimada Y; Yoshida J; Fujimoto K; Tsutsui S; Yoshida K; Kobayashi M; Kubo Y; Fujiwara S; Terasaki K; Ogasawara K
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3373-3379. PubMed ID: 30174225
[TBL] [Abstract][Full Text] [Related]
14. Posterior cerebral artery stenosis and posterior circulation revascularization surgery in pediatric patients with moyamoya disease.
Kimiwada T; Hayashi T; Shirane R; Tominaga T
J Neurosurg Pediatr; 2018 Jun; 21(6):632-638. PubMed ID: 29624146
[TBL] [Abstract][Full Text] [Related]
15. Moyamoya disease in adults: characteristics of clinical presentation and outcome after encephalo-duro-arterio-synangiosis.
Han DH; Nam DH; Oh CW
Clin Neurol Neurosurg; 1997 Oct; 99 Suppl 2():S151-5. PubMed ID: 9409427
[TBL] [Abstract][Full Text] [Related]
16. Incidence and Risk Factors of the Watershed Shift Phenomenon after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis for Adult Moyamoya Disease.
Tashiro R; Fujimura M; Kameyama M; Mugikura S; Endo H; Takeuchi Y; Tomata Y; Niizuma K; Tominaga T
Cerebrovasc Dis; 2019; 47(3-4):178-187. PubMed ID: 31121577
[TBL] [Abstract][Full Text] [Related]
17. Role of CT perfusion imaging in evaluating the effects of multiple burr hole surgery on adult ischemic Moyamoya disease.
Dai DW; Zhao WY; Zhang YW; Yang ZG; Li Q; Xu B; Ma XL; Tian B; Liu JM
Neuroradiology; 2013 Dec; 55(12):1431-8. PubMed ID: 24153446
[TBL] [Abstract][Full Text] [Related]
18. Time-course analysis of brain perfusion single photon emission computed tomography using a three-dimensional stereotactic region-of-interest template in patients with moyamoya disease.
Marushima A; Tsurushima H; Suzuki K; Nakai Y; Nemoto H; Matsumura A
World Neurosurg; 2011; 76(3-4):304-10. PubMed ID: 21986429
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Hemodynamics Before and After Revascularization in Hemorrhagic Moyamoya Disease: A Computed Tomography Perfusion Imaging Case Study.
Wang X; Chong Z; Guo X; Liu D; Sun Z; Chen Y; Gao L; Chen Y
World Neurosurg; 2019 Nov; 131():e277-e283. PubMed ID: 31351211
[TBL] [Abstract][Full Text] [Related]
20. Quantitative H2[(15)O]-PET in Pediatric Moyamoya Disease: Evaluating Perfusion before and after Cerebral Revascularization.
Kuhn FP; Warnock G; Schweingruber T; Sommerauer M; Buck A; Khan N
J Stroke Cerebrovasc Dis; 2015 May; 24(5):965-71. PubMed ID: 25813061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
